363 related articles for article (PubMed ID: 27765765)
1. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
[TBL] [Abstract][Full Text] [Related]
2. Association between ceramides and coronary artery stenosis in patients with coronary artery disease.
Tu C; Xie L; Wang Z; Zhang L; Wu H; Ni W; Li C; Li L; Zeng Y
Lipids Health Dis; 2020 Jun; 19(1):151. PubMed ID: 32586390
[TBL] [Abstract][Full Text] [Related]
3. Plasma Ceramides and Cardiovascular Events in Hypertensive Patients at High Cardiovascular Risk.
Yin W; Li F; Tan X; Wang H; Jiang W; Wang X; Li S; Zhang Y; Han Q; Wang Y; Du J
Am J Hypertens; 2021 Nov; 34(11):1209-1216. PubMed ID: 34232291
[TBL] [Abstract][Full Text] [Related]
4. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
[TBL] [Abstract][Full Text] [Related]
5. Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus.
Hilvo M; Jylhä A; Lääperi M; Jousilahti P; Laaksonen R
Eur Heart J Open; 2021 Nov; 1(3):oeab010. PubMed ID: 35919880
[TBL] [Abstract][Full Text] [Related]
6. Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea).
Wang DD; Toledo E; Hruby A; Rosner BA; Willett WC; Sun Q; Razquin C; Zheng Y; Ruiz-Canela M; Guasch-Ferré M; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Ros E; Lapetra J; Fito M; Aros F; Serra-Majem L; Lee CH; Clish CB; Liang L; Salas-Salvadó J; Martínez-González MA; Hu FB
Circulation; 2017 May; 135(21):2028-2040. PubMed ID: 28280233
[TBL] [Abstract][Full Text] [Related]
7. Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy.
Timmerman N; Waissi F; Dekker M; de Borst GJ; van Bennekom J; de Winter RJ; Hilvo M; Jylhä A; Pasterkamp G; de Kleijn DPV; Laaksonen R
Sci Rep; 2022 Apr; 12(1):5521. PubMed ID: 35365690
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.
Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G
Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715
[TBL] [Abstract][Full Text] [Related]
9. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
[TBL] [Abstract][Full Text] [Related]
10. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
[TBL] [Abstract][Full Text] [Related]
11. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
[TBL] [Abstract][Full Text] [Related]
12. Ceramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies.
Mantovani A; Dugo C
J Clin Lipidol; 2020; 14(2):176-185. PubMed ID: 32067904
[TBL] [Abstract][Full Text] [Related]
13. Plasma Ceramides.
Meeusen JW; Donato LJ; Bryant SC; Baudhuin LM; Berger PB; Jaffe AS
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1933-1939. PubMed ID: 29903731
[TBL] [Abstract][Full Text] [Related]
14. Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.
Wretlind A; Curovic VR; Suvitaival T; Theilade S; Tofte N; Winther SA; Vilsbøll T; Vestergaard H; Rossing P; Legido-Quigley C
Diabetes; 2023 Oct; 72(10):1493-1501. PubMed ID: 37478203
[TBL] [Abstract][Full Text] [Related]
15. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175
[TBL] [Abstract][Full Text] [Related]
16. Association of cardiac biomarkers with long-term cardiovascular events in a community cohort.
Churchill RA; Gochanour BR; Scott CG; Vasile VC; Rodeheffer RJ; Meeusen JW; Jaffe AS
Biomarkers; 2024 Jun; 29(4):161-170. PubMed ID: 38666319
[TBL] [Abstract][Full Text] [Related]
17. Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study.
Aalto K; Havulinna AS; Jalkanen S; Salomaa V; Salmi M
Circ Cardiovasc Genet; 2014 Aug; 7(4):529-35. PubMed ID: 24850810
[TBL] [Abstract][Full Text] [Related]
18. Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial.
Targher G; Lunardi G; Mantovani A; Meessen J; Bonapace S; Temporelli PL; Nicolis E; Novelli D; Conti A; Tavazzi L; Maggioni AP; Latini R
ESC Heart Fail; 2020 Dec; 7(6):3288-3297. PubMed ID: 32627354
[TBL] [Abstract][Full Text] [Related]
19. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.
Mantovani A; Bonapace S; Lunardi G; Canali G; Dugo C; Vinco G; Calabria S; Barbieri E; Laaksonen R; Bonnet F; Byrne CD; Targher G
Diabetes Metab; 2020 Apr; 46(2):150-157. PubMed ID: 31386900
[TBL] [Abstract][Full Text] [Related]
20. Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients.
Michelucci E; Rocchiccioli S; Gaggini M; Ndreu R; Berti S; Vassalle C
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
